Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Each (.02 cent) share of TBP has a deficient of .34 cents

<< Previous

Bullboard Posts

Next >>

Comment by SamV21on Mar 06, 2023 3:52pm

118 Views

Post# 35322132

RE:RE:RE:RE:Each (.02 cent) share of TBP has a deficient of .34 cents

Approval: You’ll get a notification that your project has been approved, along with logins for their project reporting system and other administrative forms to fill.
+1 month: You’ll have your first project review meeting with your ITA and you’ll submit your report and time/expenses.
+2-3 months: by this time you should have funds in your account for whatever you claimed in your first report. You’ll be submitting your next report and expenses as well.
+x months: continue filing reports through to the end of the project
Completion: the IRAP funding timeline finishes after your last project report. You’ll have a summary meeting and final report to submit.